Read this topic

Melatonin and ramelteon matter because they treat insomnia (difficulty falling or staying asleep) by working with the body's natural sleep-timing system rather than sedating the brain directly. Both are agonistsA drug or chemical that activates a receptor to produce an effect.Read more → (drugs that activate a receptor) at MT1 and MT2 melatonin receptors, the same receptors the body's own melatonin hormone uses to signal that it is night-time. For example, imagine an older adult with insomnia who cannot tolerate a benzodiazepine because of fall risk: melatonin can improve sleep onset without the sedation and dependence risk of stronger hypnotics. This receptor-based mechanism is also why melatonin helps resynchronise the body clock after jet lag or shift work, not just sleep onset alone.

Melatonin and ramelteon activate MT1 and MT2 receptors in the suprachiasmatic nucleus (the brain's master body clock), signalling that it is time to sleep and helping shift the timing of the sleep-wake cycle. Unlike benzodiazepines or Z-drugs, they cause little sedative hangover and carry low dependence potential, which makes them attractive for longer-term use. Take a child with a neurodevelopmental condition and a disrupted sleep-wake pattern: melatonin is often first-line because it is well tolerated even in children. In practice, this profile also makes melatonin a preferred choice in older adults, where falls and next-day sedation from other hypnotics carry a high cost.

• A student asks where melatonin is produced in the body and what regulates its release. Which answer is correct?
• A boy with autism spectrum disorder has severe difficulty falling asleep despite consistent behavioural measures. Which medication has the best evidence in this situation?
• Ramelteon should not be combined with fluvoxamine. Which pharmacokinetic mechanism underlies this specific contraindication?
• A man flying east across six time zones asks how to use melatonin for jet lag. Which timing of dosing is most appropriate?

• Benzodiazepines, sedate directly via GABAThe brain's main calming (inhibitory) chemical messenger, boosted by benzodiazepines and alcohol.Read more → receptors and carry dependence risk, unlike melatonin and ramelteon which act on melatonin receptors with low dependence.
• Z-drugs such as zolpidem, also carry dependence and next-day sedation risk, whereas melatonin is generally well tolerated in older adults and children.
• Zopiclone, a GABAThe brain's main calming (inhibitory) chemical messenger, boosted by benzodiazepines and alcohol.Read more →-acting hypnotic effective for short-term insomnia, unlike melatonin's slower, circadian-resynchronising action.
• Antihistamines used for sleep, such as promethazine: cause anticholinergicBlocking the action of acetylcholine, a nerve chemical, causing effects like a dry mouth and blurred vision.Read more → side effects (dry mouth, blurred vision, constipation), unlike melatonin which does not.

• That gland secretes quite different hormones.
• Light suppresses rather than stimulates this hormone's release.
• That sedative carries dependence risk and is not recommended here.
• That antihistamine has weaker evidence and more anticholinergicBlocking the action of acetylcholine, a nerve chemical, causing effects like a dry mouth and blurred vision.Read more → burden.
• That antidepressant is not a recommended treatment for this problem.

• Identify the drug, receptor, enzyme or pharmacokinetic change named in the stem.
• Translate it into the immediate mechanism before looking at the options.
• Use timing and the adverse-effect pattern to separate the nearest alternatives.
• Check whether the question asks for mechanism, clinical consequence, monitoring or management.